We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BBY:NYSEBest Buy Co., Inc. Analysis

Data as of 2026-03-13 - not real-time

$62.59

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Best Buy posted a solid earnings beat, delivering EPS above analyst expectations while revenue was marginally shy of forecasts, which ignited fresh analyst coverage and a short‑term price rally. Technical indicators show the stock trading below its 20‑day and 50‑day moving averages, with a bearish MACD crossover and RSI in the mid‑40s, suggesting lingering downside pressure despite the recent bounce. The dividend yield remains attractive at over 6%, and the payout ratio, while high, is supported by robust operating cash flow and positive free cash flow. However, the discounted cash‑flow model values the company at roughly half its current market price, indicating that the market may be pricing in optimistic growth assumptions that are not fully justified by the fundamentals.
Given the blend of strong cash generation, an appealing dividend, and an overvalued price relative to intrinsic estimates, investors should weigh the short‑term upside from earnings momentum against the longer‑term valuation gap and sector cyclicality. Maintaining a cautious stance—favoring income and stability while monitoring price action around key support levels—aligns with the current risk‑reward profile.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Recent earnings beat and momentum rally
  • Attractive dividend yield
  • Price near technical support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Current market price exceeds intrinsic DCF valuation
  • Stable cash flow generation supporting dividend
  • Bearish technical backdrop limiting upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High valuation relative to fundamentals
  • Consumer‑cyclical exposure to economic cycles
  • Sustainable dividend providing income return

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin2.56%
P/E Ratio12.4
ROE37.04%
ROA7.52%
Debt/Equity139.44
P/B Ratio4.4
Op. Cash Flow$2.0B
Free Cash Flow$689.5M

Technical Analysis

TrendBearish
RSI41.4
Support$60.51
Resistance$68.38
MA 20$64.43
MA 50$66.31
MA 200$71.61
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value$33.17
Target Price$74.85
Upside/Downside19.59%
GradeOvervalued
TypeValue
Dividend Yield6.13%

Risk Assessment

Beta1.40
Volatility38.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.